Fig. 10.
Cytotoxicity assay of the purified CD8+IFN-γ+ and CD8+IFN-γ− or CD4+IFN-γ+ and CD4+IFN-γ− after sensitization with allogeneic EBV BLCL of donor B.
(A) Sensitization of donor T cells with allogeneic EBV BLCL permits the generation CD8+IFN-γ+ T cells, capable of lysing the stimulating allogeneic target cells. (B) Cytolytic activity of the CD8+IFN-γ− cells. (C, D) No cytotoxic potential of the CD4+IFN-γ+ or CD4+IFN-γ− subpopulations.